For decades, therapeutic monoclonal antibody (mAb) production relied on traditional batch-based manufacturing using stainless steel systems. But as biopharmaceutical pipelines grow to meet rising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback